Name: J&J expects to deliver 20 million doses in U.S. by March-end
Uploaded: 2021-02-25T19:00:05.000Z
Duration: 1 min 11 s
Description: Thousands of YouTube videos with English-Chinese subtitles! Now you can learn to understand native speakers, expand your vocabulary, and improve your pronunciation...

Although we're cautious not to prejudge the outcome of the ongoing FDA review process, we believe that our single dose vaccine will be a critical tool for fighting this global pandemic.

28 days after vaccination, the vaccine provided complete protection against Kobe 19 related hospital in hospitalization and death.

The vaccine was 85% effective overall in preventing severe disease, including across countries with newly emerging variants.

The vaccine was 72% effective in the United States at preventing moderate to severe disease.

Based on these data earlier this month, we saw emergency use authorization from the FDA.

The FDA is advisory committee will meet later this week.

 Assuming necessary regulatory approvals, we're ready to begin shipping immediately and deliver enough single doses by the end of March to enable the vaccination of more than 20 million Americans. 

Subtitles ListPlay Video

J&J expects to deliver 20 million doses in U.S. by March-end

assume

process

pandemic

critical